IN THIS ISSUE
Managing Editor's Memo
Frank Diamond
Medication Management
Thomas Reinke

Domenica Rubino, MD

Liraglutide, used to lower HbA1c levels, can also aid with weight reduction. Should health plans cover it for this use?
Legislation & Regulation
Richard Mark Kirkner

James Robinson, PhD, MPH

Plans make the case that what patients pay above reference price for services should not count
The Formulary Files
Krishna Rutvij Patel, PharmD
Medical Device Monitor
Katherine T. Adams
Tomorrow’s Medicine
Thomas Morrow, MD
By measuring the inflammatory marker CD154, Pleximmune promises to predict the risk of organ rejection in liver and small-bowel transplant procedures
Managed Care Outlook
News & Commentary